About Ian Read
Ian Read is a director at Empery Digital.
Form D filings name Ian Read as a director at Areteia Therapeutics.
Ian Read reports to the SEC as a director or officer of 6 public companies, including Viatris (VTRS), Kimberly Clark (KMB) and DXC Technology (DXC).
Ian Read first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Ian Read in the role, so the role may have started earlier or lasted longer.
EI
Empery Digital Inc.
Director
2025 · Public company (EMPD)
VI
Viatris Inc
Director
2020 – 2022 · Public company (VTRS)
KC
Kimberly Clark Corp.
Director
2007 – 2022 · Public company (KMB)
DC
DXC Technology Co
Director
2020 – 2021 · Public company (DXC)
PI
Population Health Investment Co., Inc.
Executive Chairman
2020 · Public company (PHIC)
PI
Pfizer Inc.
Executive Chairman
2006 – 2019 · Public company (PFE)
Key Colleagues at Startups
The people Ian Read works with at each company, as listed on that company's latest Form D.
Areteia Therapeutics, Inc. · Form D/A, Feb 21, 2025
BG
Benjamin Gomez
Director
AK
Adam Koppel
Director
MB
Michael Bozik
Director
DB
Daniel Becker
Director
RW
Robin Walker
Executive officer
PB
Paul Berns
Director
CC
Christopher Courts
Executive officer
SB
Stephen Butts
Director
JB
Jorge Bartolome
Chief Executive Officer and director
ES
Elyse Stock
Director